- Home
- APRE vs MNDR Comparison
APRE vs MNDR Comparison
Compare APRE & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- MNDR
- Stock Information
- Founded
- APRE 2006
- MNDR 2016
- Country
- APRE United States
- MNDR Singapore
- Employees
- APRE N/A
- MNDR N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- MNDR
- Sector
- APRE Health Care
- MNDR
- Exchange
- APRE Nasdaq
- MNDR Nasdaq
- Market Cap
- APRE 9.7M
- MNDR 6.2M
- IPO Year
- APRE 2019
- MNDR 2024
- Fundamental
- Price
- APRE $1.65
- MNDR $1.43
- Analyst Decision
- APRE Strong Buy
- MNDR
- Analyst Count
- APRE 2
- MNDR 0
- Target Price
- APRE $15.50
- MNDR N/A
- AVG Volume (30 Days)
- APRE 17.1K
- MNDR 200.4K
- Earning Date
- APRE 05-20-2025
- MNDR 05-20-2025
- Dividend Yield
- APRE N/A
- MNDR N/A
- EPS Growth
- APRE N/A
- MNDR N/A
- EPS
- APRE N/A
- MNDR N/A
- Revenue
- APRE $1,502,581.00
- MNDR $13,968,535.00
- Revenue This Year
- APRE N/A
- MNDR $188,831.77
- Revenue Next Year
- APRE N/A
- MNDR $76.44
- P/E Ratio
- APRE N/A
- MNDR N/A
- Revenue Growth
- APRE 157.63
- MNDR 77.38
- 52 Week Low
- APRE $1.41
- MNDR $0.23
- 52 Week High
- APRE $5.90
- MNDR $26.00
- Technical
- Relative Strength Index (RSI)
- APRE 41.84
- MNDR N/A
- Support Level
- APRE $1.67
- MNDR N/A
- Resistance Level
- APRE $1.99
- MNDR N/A
- Average True Range (ATR)
- APRE 0.14
- MNDR 0.00
- MACD
- APRE 0.04
- MNDR 0.00
- Stochastic Oscillator
- APRE 41.55
- MNDR 0.00
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About MNDR Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.